Your browser doesn't support javascript.
loading
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer.
Adamson, Beth; Brittain, Nicholas; Walker, Laura; Duncan, Ruaridh; Luzzi, Sara; Rescigno, Pasquale; Smith, Graham; McGill, Suzanne; Burchmore, Richard Js; Willmore, Elaine; Hickson, Ian; Robson, Craig N; Bogdan, Denisa; Jimenez-Vacas, Juan M; Paschalis, Alec; Welti, Jonathan; Yuan, Wei; McCracken, Stuart R; Heer, Rakesh; Sharp, Adam; de Bono, Johann S; Gaughan, Luke.
Affiliation
  • Adamson B; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Brittain N; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Walker L; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Duncan R; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Luzzi S; Newcastle University Biosciences Institute, International Centre for Life, Newcastle Upon Tyne, United Kingdom.
  • Rescigno P; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Smith G; Newcastle University Bioinformatics Support Unit, Medical School, Newcastle Upon Tyne, United Kingdom.
  • McGill S; Glasgow Polyomics, Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Burchmore RJ; Glasgow Polyomics, Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Willmore E; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Hickson I; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Robson CN; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Bogdan D; The Institute for Cancer Research, London, United Kingdom.
  • Jimenez-Vacas JM; The Institute for Cancer Research, London, United Kingdom.
  • Paschalis A; The Institute for Cancer Research, London, United Kingdom.
  • Welti J; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Yuan W; The Institute for Cancer Research, London, United Kingdom.
  • McCracken SR; The Institute for Cancer Research, London, United Kingdom.
  • Heer R; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • Sharp A; Newcastle University Centre for Cancer, Paul O'Gorman Building, Newcastle Upon Tyne, United Kingdom.
  • de Bono JS; Division of Surgery, Imperial College London, London, United Kingdom.
  • Gaughan L; The Institute for Cancer Research, London, United Kingdom.
J Clin Invest ; 133(22)2023 11 15.
Article in En | MEDLINE | ID: mdl-37751307
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: J Clin Invest Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: J Clin Invest Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos